FDA, CDC And Other Federal Agencies Discuss Marijuana Research Barriers, State Legalization Models And CBD Regulations At National Academies Meeting

Representatives of multiple federal agencies participated in a National Academies of Sciences, Engineering and Medicine (NASEM) meeting on Friday for a wide-ranging discussion about cannabis policy, with experts sharing their perspective on issues such as marijuana research barriers under prohibition, efforts to create a regulated pathway for CBD, state initiatives to promote social equity and … Continue reading FDA, CDC And Other Federal Agencies Discuss Marijuana Research Barriers, State Legalization Models And CBD Regulations At National Academies Meeting